< Back to search
Filter
New

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT07225439

Phase1, Recruiting
Active & ResponsiveNew

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

for
Prostate Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: Male

Age: 18+

Code: NCT07226713

Phase2, Recruiting
Active & ResponsiveNew

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

for
Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: The Bronx NY, Brooklyn NY, Kingston, Miami Lakes FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07761117

Phase3, Recruiting
New

Personalized Exercise Recommendations for Chronic Pelvic Pain Using Reinforcement Learning

for
Pelvic Pain, Endometriosis, Chronic Pelvic Pain
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Female

Age: 18 - 55

Code: NCT07810218

Recruiting
New

Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma

for
Ependymoma, High Grade Gliomas
Location: Chicago IL
Sponsor: Cerenome

Sex: All

Age: 6 - 21

Code: NCT07061626

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

for
Congenital Adrenal Hyperplasia
Location: Hartford CT, Atlanta GA, Ann Arbor MI, Indianapolis IN,
Sponsor: Neurocrine Switzerland GmbH

Sex: All

Age: 0 - 3

Code: NCT07536269

Phase2, Recruiting
New

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

for
Atrial Fibrillation
Location: Manhattan NY, Montreal, Haddon Heights NJ, Littleton CO,
Sponsor: Milestone Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06716021

Phase3, Recruiting
New

Pedal Pump Clinical Trial on Edema V2

for
Lower Extremity Edema, Lower Extremity Edema Chronic,
Location: Tulsa OK
Sponsor: Hillcrest

Sex: All

Age: 18+

Code: NCT07809516

Recruiting
New

Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment

for
Venous Leg Ulcers (VLUs)
Location: Fort Wayne IN
Sponsor: Feeltect Limited

Sex: All

Age: 18+

Code: NCT07152717

Recruiting
New

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

for
HIV
Location: New York NY, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT07665372

Recruiting
New

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

for
Intracranial Venous Blood, Brain Cancers, Liquid Biopsy,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07467109

Recruiting
New

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: The Bronx NY, New York NY, Bel Air MD, Glen Burnie MD,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase3, Recruiting
Active & ResponsiveNew

Study of Oral Food Challenge Biomarkers (SAFER)

for
Allergy
Location: New York NY, Baltimore MD, Palo Alto CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 17

Code: NCT07279467

Recruiting
Active & ResponsiveNew

Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis

for
Clinical High Risk for Psychosis (CHR)
Location: Toronto
Sponsor: Centre for Addiction and Mental Health

Sex: All

Age: 14 - 35

Code: NCT06928935

Recruiting
New

A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines

for
Glabellar Lines
Location: Chestnut Hill MA, Wilmington NC, Nashville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07756580

Phase1, Recruiting
Active & ResponsiveNew

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 4 - 34

Code: NCT07216391

Phase2, Recruiting
New

Georgia CEAL RESTORES Family Diabetes Study

for
Weight Reduction, Prediabetes
Location: Atlanta GA
Sponsor: Morehouse School of Medicine

Sex: All

Age: 12+

Code: NCT07808723

Recruiting
New

Breast Artery Calcification (BAC) and Female Cardiovascular Disease

for
Cardiovascular Health Risk Communication,
Location: Manhasset NY
Sponsor: Northwell Health

Sex: Female

Age: 55 - 65

Code: NCT07809932

Recruiting
New

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

for
Secondary Immune Deficiency
Location: Bethesda MD, Coral Springs FL
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07648264

Phase3, Recruiting
Active & ResponsiveNew

Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina

for
Opioid Use Disorder, Digital Health Intervention, Telemedicine,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07810322

Recruiting